Press release
Increasing Worldwide Prevalence of Parkinson’s Disease Increasing Elderly Population Drives the Stereotactic Surgery Devices Market
Stereotactic surgery devices such as stereotactic frames, image-based planning software specifically designed for stereotactic surgery and radio frequency generator are widely used during stereotactic surgery. Stereotactic surgery also known as stereotaxy is a kind of minimally invasive procedure that is used for both diagnostic and therapeutic purposes. Stereotactic surgery involves the use of a three-dimensional coordinate system to stereotactically localize any point in 3D space, and to perform procedures such as injection, ablation, lesion, implantation, biopsy and radiosurgery. Image-based planning software plays a key role in guiding the surgeon towards the target in his approach.Download Exclusive Sample of this Report: http://bit.ly/2g1fJM0
The world is witnessing an increasing adoption of stereotactic procedure by surgeons for various neurosurgeries particularly related with Parkinson's disease, epilepsy, arteriovenous malformations (AVMs) and other conditions, primarily with intent to achieve a high level of accuracy during localizing intracranial targets. Increasing worldwide prevalence of Parkinson’s disease, epilepsy and AVMs and rapidly increasing elderly population are some of the major drivers for the stereotactic surgery devices market. As per the statistics released by the European Parkinson’s Disease Association, more than 6.3 million people are living with Parkinson’s disease across the globe.
According to the U.S. Parkinson’s Disease Foundation, every year more than 60,000 Americans are diagnosed with Parkinson’s disease across the nation. According to the Epilepsy Foundation, epilepsy has been identified as the 4th most common neurological problem. The Epilepsy Foundation further states that approximately 2.2 million people are living with epilepsy in the U.S. The occurrence rate of AVMs is less than 1% of the general population and is more commonly seen in males than females. The American Heart Association reported that about one in 200 to 500 people could have an AVM in 2014. On account of such high prevalence of neurological diseases, the global market for stereotactic surgery devices market has been expected to grow significantly during the forecast period between 2014 and 2020.
Elderly population is at high risk of developing various neurological diseases, for example, Parkinson’s disease usually affechttp://bit.ly/2g1fJM0ts people aged 60 years or older. Therefore, continuously increasing elderly population is expected to directly impact the growth and development of stereotactic surgery devices market. According to the World Health Organization (WHO) projections, in 2010, global geriatric population was around 524 million and is anticipated to reach around 1.5 billion by the year 2050.
Concerted efforts by the key manufacturers in the research and development of stereotactic surgery devices is one of the major reasons driving the market growth across the globe. The new and innovative products developed as a result of extensive research and development activities offers improved clinical outcomes, broader procedural options and shorten planning time.
In terms of geography, the global market for stereotactic surgery devices has been segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). Of these, North America represented the largest regional market in 2013, followed by Europe and Asia-Pacific. Elekta AB, Inomed, Monteris Medical, adeor Medical AG, Alliance Oncology and Micromar are some of the major players operating in the stereotactic surgery devices market. These players are in constant competition with each other and are striving to get competitive edge over others. Elekta AB, a Swedish company offers Leksell Stereotactic System, Leksell SurgiPlan and Leksell Neuro Generator.
Browse Research Report: http://bit.ly/2geUMA4
Leksell Stereotactic System includes a wide range of accessories including Leksell Coordinate Frame and Leksell Multipurpose Stereotactic Arc. ZD Stereotactic System, RM Stereotactic System and OSS Open Stereotactic System are the three major types of stereotactic systems that are marketed by Inomed.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Worldwide Prevalence of Parkinson’s Disease Increasing Elderly Population Drives the Stereotactic Surgery Devices Market here
News-ID: 388694 • Views: …
More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…

North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…

Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…

Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…